SG10201702248UA - Methods for treating hepatitis c - Google Patents

Methods for treating hepatitis c

Info

Publication number: SG10201702248UA
Authority: SG; Singapore
Prior art keywords: methods; treating hepatitis; hepatitis; treating
Prior art date: 2012-09-18

Application number

SG10201702248UA

Inventor

Teresa Lok-Chan Ng

Tami J Pilot-Matias

Warren M Kati

Preethi Krishnan

Clarence J Maring

Neeta C Mistry

Thomas J Reisch

Rolf Wagner

Liu Dachun

John K Pratt

Mark A Matulenko

Ryan G Keddy

Original Assignee

Abbvie Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-18

Filing date

2013-09-17

Publication date

2017-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49304326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201702248U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-09-17 Application filed by Abbvie Inc filed Critical Abbvie Inc

2017-04-27 Publication of SG10201702248UA publication Critical patent/SG10201702248UA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Virology (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SG10201702248UA 2012-09-18 2013-09-17 Methods for treating hepatitis c SG10201702248UA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261702564P	2012-09-18	2012-09-18

Publications (1)

Publication Number	Publication Date
SG10201702248UA true SG10201702248UA (en)	2017-04-27

Family

ID=49304326

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10201702248UA SG10201702248UA (en)	2012-09-18	2013-09-17	Methods for treating hepatitis c
SG11201502095SA SG11201502095SA (en)	2012-09-18	2013-09-17	Methods for treating hepatitis c

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201502095SA SG11201502095SA (en)	2012-09-18	2013-09-17	Methods for treating hepatitis c

Country Status (25)

Country	Link
US (1)	US20140080868A1 (en)
EP (2)	EP2897611B1 (en)
JP (4)	JP6297044B2 (en)
CN (1)	CN104797253A (en)
AU (2)	AU2013318302B2 (en)
BR (1)	BR112015006037B1 (en)
CA (1)	CA2884539C (en)
CY (1)	CY1122442T1 (en)
DK (1)	DK2897611T3 (en)
ES (1)	ES2755089T3 (en)
HR (1)	HRP20191939T1 (en)
HU (1)	HUE046544T2 (en)
LT (1)	LT2897611T (en)
MX (2)	MX367796B (en)
NZ (1)	NZ630581A (en)
PL (1)	PL2897611T3 (en)
PT (1)	PT2897611T (en)
RS (1)	RS59640B1 (en)
RU (1)	RU2665365C2 (en)
SG (2)	SG10201702248UA (en)
SI (1)	SI2897611T1 (en)
SM (1)	SMT201900683T1 (en)
TW (1)	TWI621436B (en)
WO (1)	WO2014047039A1 (en)
ZA (1)	ZA201501752B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG10201702248UA (en) *	2012-09-18	2017-04-27	Abbvie Inc	Methods for treating hepatitis c
WO2017007934A1 (en) *	2015-07-08	2017-01-12	Abbvie Inc.	Methods for treating hcv
US11484534B2 (en)	2013-03-14	2022-11-01	Abbvie Inc.	Methods for treating HCV
PT3213750T (en) *	2013-03-14	2020-10-19	Abbvie Inc	Combination of two antivirals for treating hepatitis c
MX2016012722A (en) *	2014-04-02	2016-12-16	Abbvie Inc	Methods for treating hcv.
BR112016022976A8 (en)	2014-04-02	2021-07-20	Abbvie Inc	methods for treating hcv
RU2018102809A (en) *	2015-06-26	2019-07-29	Эббви Инк.	SOLID PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HEPATITIS C VIRUS
US20160375017A1 (en)	2015-06-26	2016-12-29	Abbvie Inc.	Solid Pharmaceutical Compositions for Treating HCV
BR112018000982A2 (en) *	2015-07-17	2018-09-11	Abbvie Inc	solid pharmaceutical compositions for treating hcv
EA201892448A1 (en)	2016-04-28	2019-06-28	Эмори Юниверсити	ALKYN-CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND RELATED APPLICATION METHODS
AU2021391823A1 (en)	2020-12-03	2023-06-29	Battelle Memorial Institute	Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
IL307454A (en)	2021-04-07	2023-12-01	Battelle Memorial Institute	Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
GB202113944D0 (en) *	2021-09-29	2021-11-10	Univ Liverpool	Injectable formulations
WO2025072751A1 (en)	2023-09-29	2025-04-03	Battelle Memorial Institute	Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en)	2023-12-08	2025-06-12	Battelle Memorial Institute	Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070274951A1 (en) *	2006-02-09	2007-11-29	Xiao Tong	Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
AR075584A1 (en) *	2009-02-27	2011-04-20	Intermune Inc	THERAPEUTIC COMPOSITIONS THAT INCLUDE beta-D-2'-DESOXI-2'-FLUORO-2'-C-METHYLYCTIDINE AND A CARDIEX ISOINDOL ACID DERIVATIVE AND ITS USES. COMPOUND.
US8937150B2 (en) *	2009-06-11	2015-01-20	Abbvie Inc.	Anti-viral compounds
US9394279B2 (en) *	2009-06-11	2016-07-19	Abbvie Inc.	Anti-viral compounds
AR088408A1 (en) *	2011-10-21	2014-05-28	Abbvie Inc	METHODS FOR HCV TREATMENT
SG10201702248UA (en) *	2012-09-18	2017-04-27	Abbvie Inc	Methods for treating hepatitis c

2013
- 2013-09-17 SG SG10201702248UA patent/SG10201702248UA/en unknown
- 2013-09-17 US US14/029,302 patent/US20140080868A1/en not_active Abandoned
- 2013-09-17 HU HUE13773463A patent/HUE046544T2/en unknown
- 2013-09-17 ES ES13773463T patent/ES2755089T3/en active Active
- 2013-09-17 DK DK13773463T patent/DK2897611T3/en active
- 2013-09-17 EP EP13773463.8A patent/EP2897611B1/en active Active
- 2013-09-17 AU AU2013318302A patent/AU2013318302B2/en active Active
- 2013-09-17 RS RS20191378A patent/RS59640B1/en unknown
- 2013-09-17 MX MX2015003501A patent/MX367796B/en active IP Right Grant
- 2013-09-17 BR BR112015006037-4A patent/BR112015006037B1/en active IP Right Grant
- 2013-09-17 CN CN201380060100.7A patent/CN104797253A/en active Pending
- 2013-09-17 SG SG11201502095SA patent/SG11201502095SA/en unknown
- 2013-09-17 SM SM20190683T patent/SMT201900683T1/en unknown
- 2013-09-17 PT PT137734638T patent/PT2897611T/en unknown
- 2013-09-17 CA CA2884539A patent/CA2884539C/en active Active
- 2013-09-17 EP EP19187747.1A patent/EP3597190A1/en active Pending
- 2013-09-17 NZ NZ630581A patent/NZ630581A/en unknown
- 2013-09-17 RU RU2015114543A patent/RU2665365C2/en active
- 2013-09-17 JP JP2015532139A patent/JP6297044B2/en active Active
- 2013-09-17 HR HRP20191939TT patent/HRP20191939T1/en unknown
- 2013-09-17 WO PCT/US2013/060103 patent/WO2014047039A1/en not_active Ceased
- 2013-09-17 LT LT13773463T patent/LT2897611T/en unknown
- 2013-09-17 PL PL13773463T patent/PL2897611T3/en unknown
- 2013-09-17 SI SI201331607T patent/SI2897611T1/en unknown
- 2013-09-18 TW TW102133969A patent/TWI621436B/en active
2015
- 2015-03-13 ZA ZA2015/01752A patent/ZA201501752B/en unknown
- 2015-03-18 MX MX2019010600A patent/MX2019010600A/en unknown
2018
- 2018-02-19 JP JP2018026645A patent/JP6556884B2/en active Active
- 2018-05-22 AU AU2018203608A patent/AU2018203608B2/en active Active
2019
- 2019-07-11 JP JP2019128933A patent/JP2019194241A/en active Pending
- 2019-10-24 CY CY20191101109T patent/CY1122442T1/en unknown
2020
- 2020-12-21 JP JP2020211042A patent/JP2021054849A/en active Pending

Also Published As

Publication number	Publication date
SI2897611T1 (en)	2019-12-31
TW201412311A (en)	2014-04-01
MX367796B (en)	2019-09-06
JP2015528511A (en)	2015-09-28
SG11201502095SA (en)	2015-05-28
RU2665365C2 (en)	2018-08-29
HK1209319A1 (en)	2016-04-01
EP3597190A1 (en)	2020-01-22
PL2897611T3 (en)	2020-03-31
ZA201501752B (en)	2016-08-31
RU2015114543A (en)	2016-11-10
RS59640B1 (en)	2020-01-31
WO2014047039A1 (en)	2014-03-27
JP6297044B2 (en)	2018-03-20
MX2015003501A (en)	2015-10-26
JP2021054849A (en)	2021-04-08
EP2897611A1 (en)	2015-07-29
ES2755089T3 (en)	2020-04-21
NZ630581A (en)	2017-02-24
HUE046544T2 (en)	2020-03-30
US20140080868A1 (en)	2014-03-20
JP2019194241A (en)	2019-11-07
LT2897611T (en)	2019-12-10
AU2018203608B2 (en)	2019-12-19
EP2897611B1 (en)	2019-07-24
AU2018203608A1 (en)	2018-06-14
AU2013318302B2 (en)	2018-02-22
BR112015006037B1 (en)	2022-05-17
DK2897611T3 (en)	2019-11-04
HRP20191939T1 (en)	2020-01-10
CY1122442T1 (en)	2021-01-27
SMT201900683T1 (en)	2020-01-14
PT2897611T (en)	2019-11-27
JP6556884B2 (en)	2019-08-07
BR112015006037A2 (en)	2017-07-04
JP2018109035A (en)	2018-07-12
TWI621436B (en)	2018-04-21
CN104797253A (en)	2015-07-22
MX2019010600A (en)	2020-02-03
CA2884539C (en)	2022-06-21
CA2884539A1 (en)	2014-03-27
AU2013318302A1 (en)	2015-04-02

Publication	Publication Date	Title
ZA201501752B (en)	2016-08-31	Methods for treating hepatitis c
IL231515A0 (en)	2014-04-30	Methods for treating hcv
ZA201500603B (en)	2016-10-26	Process
IL235062A0 (en)	2014-12-31	Compounds and methods for antiviral treatment
EP2757887A4 (en)	2015-05-27	Pyrrolopyridinone compounds and methods for treating hiv
SG2014010490A (en)	2014-04-28	Combination treatments for hepatitis c
ZA201906339B (en)	2021-07-28	Methods for treating pruritus
GB201207997D0 (en)	2012-06-20	Process
ZA201501758B (en)	2016-01-27	Methods for treating hepatitis c
SG11201500381TA (en)	2015-02-27	Process
EP2852660A4 (en)	2016-03-09	Process
ZA201502344B (en)	2016-10-26	Process
ZA201406172B (en)	2016-05-25	Compounds and methods for treating leukemia
EP2854774A4 (en)	2015-11-18	Methods for treating insomnia
GB201214387D0 (en)	2012-09-26	Methods for treating plants
GB201209932D0 (en)	2012-07-18	Improved process
GB201205449D0 (en)	2012-05-09	Treatment process
GB201213874D0 (en)	2012-09-19	Process
GB201211099D0 (en)	2012-08-01	Process
GB201209279D0 (en)	2012-07-04	Process
GB201205665D0 (en)	2012-05-16	Process
GB201205052D0 (en)	2012-05-09	Process